Sandy Spring Bank’s Pulse Biosciences PLSE Stock Holding History

Sandy Spring Bank’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-15	Closed	–	–	871
2017 Q4	$0	Buy	+15	New	+$354	﹤0.01%	875
2017 Q3	–	Sell	-15	Closed	-$1K	–	838
2017 Q2	$1K	Buy	+15	New	+$412	﹤0.01%	822

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sandy Spring Bank's PLSE Position: Q1 2018 in Review

Sandy Spring Bank sold out of Pulse Biosciences (PLSE) in Q1 2018, closing a stake of 15 shares.

Sandy Spring Bank first reported a position in PLSE in Q2 2017 and held it in 2 quarters. The position peaked at $1K in Q2 2017. 47 funds tracked by Wall St. Rank hold PLSE as of Q1 2018.

Sandy Spring Bank reported no remaining Pulse Biosciences position as of Q1 2018 after selling out during the quarter.
Sandy Spring Bank sold 15 Pulse Biosciences shares in Q1 2018.
Sandy Spring Bank first reported a position in Pulse Biosciences in Q2 2017 and held it in 2 quarters.
Sandy Spring Bank's Pulse Biosciences position peaked at $1K in Q2 2017.
47 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2018.

Based on Sandy Spring Bank's 13F filing for Q1 2018, filed 4 May 2018.